News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Michael Lai, MD, PhD

Retina Group of Washington

Articles by Michael Lai, MD, PhD

ASRS 2025: Underfunding of Good Days program affect on patients and practices

ByMichael Lai, MD, PhD,Martin David Harp,Sydney M Crago

August 5th 2025

Lai spoke with Modern Retina about the study of PER-001, a novel therapeutic targeting the endothelin-1 receptor.

Latest Updated Articles

Trending on Modern Retina

Q&A: Anat Loewenstein discusses the use of home OCT

Q&A: Kenneth Fan on MCO-010 trials for Stargardt disease

© 2025 MJH Life Sciences^®

All rights reserved.